AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: 129056-RSG-16-093
Direktion für Entwicklung und Zusammenarbeit
Grant: UG3HL147367
Direktion für Entwicklung und Zusammenarbeit
Grant: UH3HL147367
Direktion für Entwicklung und Zusammenarbeit
Grant: P30DK056338
Cystic Fibrosis Foundation
Grant: U42OD026645
NIH
Grant: DP2HL137167
NIH
Grant: P01HL131471
Intellectual and Developmental Disabilities Research Center
Grant: P50HD103555
NHLBI NIH HHS
Grant: P01 HL158506
NIH
FWCI
2.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
Additional file 1 of Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
Additional file 2 of Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
Additional file 2 of Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2